Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


PINL:CTABF - Post by User

Canntab Therapeutics Ltd > Company is poised to grow!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by julian88on Sep 26, 2018 11:21pm
82 Views
Post# 28698287

RE:RE:RE:RE:RE:RE:RE:Company is poised to grow!

RE:RE:RE:RE:RE:RE:RE:Company is poised to grow!Lol yes there are costs in training and infastructure but a building that size I am sure the lease for one year  would be no more than 300k a year and not sure how many people you can put in a phone booth? Lets say 30-50 staff to train is peanuts if you get approval and contracts signed. 
10-15 people working the lab and processing can generate millions per month in hard work with huge margins in a building half that size! Not sure how you think 30 million is in play unless management take huge salaries but as you may know the compensation would be in stock incentives. Pretty easy to generate a financing if there are sales contracts. 
We both agree that this is a winner either way! 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities